Current and future roles of biosimilars in oncology practice
Current and future roles of biosimilars in oncology practice - PMC
Biosimilars are more affordable drugs, but with a similar safety and toxicity profile and no clinically meaningful differences compared with ...
Current and future roles of biosimilars in oncology practice - PubMed
Biologics have been used increasingly in the treatment and supportive care of cancer; however, their high cost places a significant burden on healthcare ...
Current and future roles of biosimilars in oncology practice (Review)
The expiration of patents for biologics has led to the development of biosimilars, with the aim of reducing cost and increasing accessibility to ...
(PDF) Current and future roles of biosimilars in oncology practice ...
PDF | On Nov 15, 2019, Sofia Konstantinidou and others published Current and future roles of biosimilars in oncology practice (Review) | Find, read and cite ...
ASK | Abstract | Current and future roles for biosimilars in oncology
Biologics account for half the pharmacological market in oncology; however, their main drawback is their high cost. Biosimilars were developed as cheaper ...
Current and future roles of biosimilars in oncology practice
The present review aims to provide an overview of the biosimilars used in Europe and the USA, present their main benefits and challenges, and discuss their ...
Biosimilars in Oncology Practice: A Multi-Site Health System ...
The future direction of cancer involves effective and safe cancer treatments as well as greater access to affordable therapies. Biosimilars introduce an ...
Biosimilars Resource Library - ACCC Cancer
The Biosimilars Implementation Roadmap is an innovative learning tool that can help multidisciplinary cancer care teams obtain the ...
Use of Biosimilar Medications in Oncology - ASCO Publications
At present, ASCO has supported the integration of FDA approved biosimilars into clinical practice guidelines as equally safe and efficacious to ...
Use of Biosimilar Medications in Oncology - ASCO Publications
The increased number and expanded utilization of biosimilars raise important considerations for their safe and appropriate use in oncology practice.
Biosimilars in Oncology: From Development to Clinical Practice
Biologics play an integral role in the treatment of cancer not only for their therapeutic effects and ability to improve outcomes, but also as supportive ...
Biosimilars in oncology: current and future perspectives - GaBI Journal
Loss of patent protection on biopharmaceuticals enables the development and production of similar biological medicines, or biosimilars. Biosimilars are ...
Full article: Biosimilars in an Era of Rising Oncology Treatment Options
In this regard, biosimilars could potentially play an important role in increasing patient access to biologic therapies. The lower price of biosimilars has the ...
New ASCO Report Clarifies Potential Value and Utility of Biosimilars ...
“Oncology-related biosimilars were first approved by the FDA in 2015, and we currently have 17 agents approved for use. But there exist practice ...
Study Shows Increase in Biosimilar Use Among Oncology Providers
Konstantinidou S, Papaspiliou A, Kokkotou E. Current and future roles of biosimilars in oncology practice. Oncol Lett. 2020;19:45-51. · McGlynn KA, McGarry J, ...
Developing Oncology Biosimilars: An Essential Approach for the ...
Improving patient access to cancer therapies such as biologics and reducing healthcare costs are key initiatives of the US Government; the integration of ...
A narrative review of biosimilars: a continued journey from the ...
Current and future roles of biosimilars in oncology practice. Oncol Lett 2020;19:45-51. [PubMed]; Coiffier B. Preparing for a new generation of biologic ...
Cancer treatment with biosimilar drugs: A review - Wiley Online Library
Biosimilars are drugs similar in structure and function to biological medicine, known as reference biologics. Biologic medicines are derived ...
Experts Decode the Future of Biosimilars in Breast Cancer - OncLive
The introduction of biosimilars is having a growing impact on breast oncology, as these agents move from supportive care to active treatment ...
[PDF] Improving Access to Cancer Treatments: The Role of Biosimilars
The potential role and impact of biosimilars in oncology and the challenges related to their adoption and use are discussed. Biologics play a key role in ...